- Trials with a EudraCT protocol (136)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (1)
136 result(s) found for: Habits.
Displaying page 1 of 7.
EudraCT Number: 2020-000548-71 | Sponsor Protocol Number: NOK0020 | Start Date*: 2021-01-25 |
Sponsor Name:Nederlandse Obesitas Kliniek | ||
Full Title: Liraglutide for low-responders after bariatric surgery | ||
Medical condition: Morbid obesity | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2015-002230-41 | Sponsor Protocol Number: PPH-LYF02 | Start Date*: 2015-06-29 |
Sponsor Name:Landspitali University Hospital | ||
Full Title: Pharmacokinetics of Proton Pump Inhibitors in a random Icelandic Population. | ||
Medical condition: Gastro Oesophageal Reflux Disease | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: IS (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-004702-14 | Sponsor Protocol Number: 530079.01.302 | Start Date*: 2016-04-01 | |||||||||||
Sponsor Name:Dr. Willmar Schwabe GmbH & Co. KG | |||||||||||||
Full Title: Efficacy and Tolerability of Menthacarin in Patients (≥ 18 years old) suffering from symptoms of Irritable Bowel Syndrome (IBS) | |||||||||||||
Medical condition: Symptoms of Irritable Bowel Syndrome (IBS) characterized by recurrent abdominal pain, abdominal discomfort, abdominal cramping, abdominal fullness, abdominal bloating or flatulence usually accompan... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-000122-60 | Sponsor Protocol Number: 1.0 | Start Date*: 2013-05-17 |
Sponsor Name:Karolinska University Hospital, Division of Pediatrics/Astrid Lindgren Children´s Hospital | ||
Full Title: The effect of dexmedetomidine as an adjuvant to local anaesthetics for ilioinguinal blocks in paediatric patients | ||
Medical condition: Pediatric patients receive ilioinguinal-iliohypogastric nerve blockade with 0.2ml/kg ropivacaine 0.197% and 0.3µg/kg dexmedetomidine or 0.2ml/kg ropivacaine 0.197% and saline as a placebo. Aim of t... | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-000645-12 | Sponsor Protocol Number: GFT505-219-8 | Start Date*: 2019-09-03 | |||||||||||
Sponsor Name:GENFIT SA | |||||||||||||
Full Title: A Double-Blind, Placebo-Controlled, Cross-over Phase II Study to Evaluate the Effect of a 6-week Elafibranor (120mg) treatment administered once daily on hepatic lipid composition in subjects with ... | |||||||||||||
Medical condition: Subjects with Nonalcoholic Fatty Liver (NAFL) | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-003991-23 | Sponsor Protocol Number: 985/08 | Start Date*: 2008-11-05 | |||||||||||
Sponsor Name:POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI | |||||||||||||
Full Title: EFFECT OF ORAL ADMINISTRATION OF OLEASELECT TO HUMAN HEALTHY VOLUNTEERS ON METABOLIC AND INFLAMMATORY PATHWAYS RELATED TO THE RISK OF ISCHEMIC CARDIOVASCULAR DISEASE: A PILOT STUDY | |||||||||||||
Medical condition: Inadequate diet for protective factors for vascular system | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-001663-22 | Sponsor Protocol Number: na | Start Date*: 2018-09-05 |
Sponsor Name:Maastricht University | ||
Full Title: Effects of ciprofibrate on myocardial insulin sensitivity in pre-diabetes | ||
Medical condition: Insulin resistance, diastolic cardiac failure, mitochondrial function | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2011-005628-16 | Sponsor Protocol Number: Uni-Koeln-1473 | Start Date*: 2012-08-06 |
Sponsor Name:University of Cologne | ||
Full Title: FTO-genotype dependent weight reduction under treatment with bromocriptin in obese patients | ||
Medical condition: Obesity with BMI ≥ 30kg/m² | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-000213-33 | Sponsor Protocol Number: 14012020 | Start Date*: 2020-04-21 | |||||||||||
Sponsor Name:Department of Dentistry and Oral Health | |||||||||||||
Full Title: Fluoride in saliva during and after use of high-fluoride toothpaste | |||||||||||||
Medical condition: Not applicable. A physiological phenomena is explored. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-002712-51 | Sponsor Protocol Number: 2020 | Start Date*: 2021-03-05 | |||||||||||
Sponsor Name:Kirsi Pietiläinen | |||||||||||||
Full Title: Semaglutide as an adjunct to dieting in the treatment of type 2 diabetes – effects on glucose metabolism, prevention of weight regain and peripheral tissue metabolic activation | |||||||||||||
Medical condition: Type 2 diabetes | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-001386-16 | Sponsor Protocol Number: TUD-TEMACA-069 | Start Date*: 2019-07-16 |
Sponsor Name:Technische Universität Dresden | ||
Full Title: Investigation of the efficacy of acamprosate and calcium in comparison to placebo as validation of a behavioural test for alcohol dependence (TEMACA) | ||
Medical condition: persons with disturbance in alcohol use according DSM5 which do not want to change their alcohol consumption | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2019-004054-28 | Sponsor Protocol Number: Panorexia | Start Date*: 2020-06-23 | ||||||||||||||||
Sponsor Name:Imperial College London | ||||||||||||||||||
Full Title: Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study | ||||||||||||||||||
Medical condition: Anorexia Nervosa | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-001950-18 | Sponsor Protocol Number: AST014 | Start Date*: 2007-07-23 |
Sponsor Name:Ocera Therapeutics, Inc. | ||
Full Title: A DOUBLE BLIND, RANDOMIZED, PLACEBO-CONTROLLED MULTICENTER STUDY TO ASSESS THE SAFETY AND EFFICACY OF AST-120 IN PATIENTS WITH NON-CONSTIPATING IRRITABLE BOWEL SYNDROME | ||
Medical condition: Irritable bowel syndrome (IBS) is a chronic functional bowel disorder characterized by abdominal pain or discomfort and laterations in bowel habits. IBS is one of the most frequent conditions physi... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2006-002862-20 | Sponsor Protocol Number: NS2330-001 | Start Date*: 2006-08-03 | |||||||||||
Sponsor Name:NeuroSearch A/S | |||||||||||||
Full Title: Effect of tesofensine on weight reduction in patients with obesity. A randomised, double-blind, placebo-controlled, parallel-group, multi-centre study. | |||||||||||||
Medical condition: Obesity | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-020303-69 | Sponsor Protocol Number: 2010Axcan9682 | Start Date*: 2011-09-19 | |||||||||||
Sponsor Name:Erasmus MC | |||||||||||||
Full Title: Enzyme substitution in exocrine pancreatic insufficiency; Self administration against a fixed dose regimen. | |||||||||||||
Medical condition: Exocrine pancreatic insufficiency in patients with chronic pancreatitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-003124-73 | Sponsor Protocol Number: na | Start Date*: 2018-01-31 |
Sponsor Name:Maastricht University | ||
Full Title: Carnitine supplementation as a therapy to improve insulin sensitivity in Type 2 diabetic patients with low carnitine status | ||
Medical condition: Glucose tolerance | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2015-001245-89 | Sponsor Protocol Number: BDR4580 | Start Date*: 2015-04-13 | |||||||||||
Sponsor Name:Sanofi-aventis | |||||||||||||
Full Title: Relative bioavailability study between 75 mg tablet and 75 mg solution of Clopidogrel (SR25990C) after single oral administration to young healthy men. Open, crossover, randomized and monocenter study | |||||||||||||
Medical condition: Young healthy men (intended indication cardiovascular disease) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-005857-23 | Sponsor Protocol Number: MC/PR/033011/003/05 | Start Date*: 2006-05-08 | |||||||||||
Sponsor Name:CHIESI | |||||||||||||
Full Title: DOUBLE BLIND, DOUBLE DUMMY, RANDOMISED, PARALLEL GROUP, MONOCENTRIC CLINICAL TRIAL ON THE EFFECTS OF CHF 1535 MDI OR SERETIDE DPI ON LUNG HYPERINFLATION AND EXERCISE TOLERANCE IN PATIENTS WITH COPD... | |||||||||||||
Medical condition: Chronic Obstructive Pulmonary Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-004248-39 | Sponsor Protocol Number: PPI-microbiome | Start Date*: 2018-01-04 |
Sponsor Name:TARGID, KU Leuven | ||
Full Title: Effect of Proton Pump Inhibitors on the duodenal microbiome in healthy volunteers | ||
Medical condition: We will assess the effect of Proton Pump Inhibitors (PPI) on the duodenal, oral and fecal microbiota composition in healthy volunteers | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-005203-24 | Sponsor Protocol Number: V37_11 | Start Date*: 2014-12-10 |
Sponsor Name:Novartis Vaccines and Diagnostics | ||
Full Title: A Post Marketing Surveillance Study to monitor the reactogenicity and safety of Vaxem™Hib when administered according to the prescribing information in Korea | ||
Medical condition: Meningitis, epiglottitis, pneumonia, arthritis caused by Haemophilus influenzae type b. | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
